Ea. Walker et al., Three-choice discrimination in pigeons is based on relative efficacy differences among opioids, PSYCHOPHAR, 155(4), 2001, pp. 389-396
Rationale: Drug discrimination assays can provide important information on
receptor selectivity and relative efficacy to guide the classification and
characterization of opioid agonists. Objectives: A three-choice discriminat
ion was established among high efficacy opioid agonist morphine, low effica
cy opioid agonist nalbuphine, and saline to examine the conditions under wh
ich differences in relative efficacy might serve as a basis for stimulus co
ntrol. Methods: Seven White Carneau pigeons were trained to discriminate am
ong 5.6 mg/kg nalbuphine, 3.2 mg/kg morphine, and saline under fixed ratio
30 (FR30) schedules of food reinforcement. Substitution and antagonism expe
riments were then conducted with mu, kappa, and delta opioids and naltrexon
e, respectively and the percent responding appropriate to the training stim
uli was determined. Results Low, intermediate, and high doses of morphine p
roduced greater than or equal to 80% saline-, greater than or equal to 60%
nalbuphine-, and greater than or equal to 96% morphine-appropriate ate resp
onding, respectively. Low and high doses of nalbuphine produced greater tha
n or equal to 80% saline- and nalbuphine-appropriate responding, respective
ly. In substitution tests, low doses of fentanyl and etorphine produced par
tial nalbuphine-appropriate responding (20-60%) and high doses produced gre
ater than or equal to 60-80% morphine-appropriate responding. Intermediate
doses of buprenorphine and dezocine produced greater than or equal to 60-80
% nalbuphine-appropriate responding and high doses produced greater than or
equal to 80% morphine-appropriate responding. The lower efficacy agonists
butorphanol, nalorphine, and levallorphan produced greater than or equal to
40-80% nalbuphine-appropriate responding. The kappa- agonists spiradoline
and U50,488 produced approximately greater than or equal to 50% nalbuphine-
appropriate responding whereas d-amphetamine, saline, and delta agonists BW
373U86 and SNC 80 produced greater than or equal to 80% saline-appropriate
responding. Naltrexone produced greater than or equal to 80% saline-appropr
iate responding and reversed the stimulus effects of morphine and nalbuphin
e. Conclusions: The discrimination between morphine and nalbuphine in pigeo
ns is predominantly based on the relative efficacy differences between morp
hine, a higher-efficacy mu agonist and nalbuphine, a lower-efficacy mu agon
ist.